Cite

HARVARD Citation

    Yildiz, I. et al. (2018). Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy. Tumori. 104 (6), pp. 444-450. [Online]. 
  
Back to record